1. Home
  2. EARN vs AMRN Comparison

EARN vs AMRN Comparison

Compare EARN & AMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EARN
  • AMRN
  • Stock Information
  • Founded
  • EARN 2012
  • AMRN 1989
  • Country
  • EARN United States
  • AMRN Ireland
  • Employees
  • EARN N/A
  • AMRN N/A
  • Industry
  • EARN Real Estate Investment Trusts
  • AMRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • EARN Real Estate
  • AMRN Health Care
  • Exchange
  • EARN Nasdaq
  • AMRN Nasdaq
  • Market Cap
  • EARN 189.7M
  • AMRN 302.0M
  • IPO Year
  • EARN 2013
  • AMRN 1993
  • Fundamental
  • Price
  • EARN $5.34
  • AMRN $17.33
  • Analyst Decision
  • EARN Buy
  • AMRN Strong Sell
  • Analyst Count
  • EARN 2
  • AMRN 1
  • Target Price
  • EARN $5.88
  • AMRN $12.00
  • AVG Volume (30 Days)
  • EARN 350.1K
  • AMRN 142.8K
  • Earning Date
  • EARN 11-19-2025
  • AMRN 10-29-2025
  • Dividend Yield
  • EARN 17.91%
  • AMRN N/A
  • EPS Growth
  • EARN N/A
  • AMRN N/A
  • EPS
  • EARN N/A
  • AMRN N/A
  • Revenue
  • EARN $35,893,000.00
  • AMRN $219,361,000.00
  • Revenue This Year
  • EARN N/A
  • AMRN N/A
  • Revenue Next Year
  • EARN $15.93
  • AMRN N/A
  • P/E Ratio
  • EARN N/A
  • AMRN N/A
  • Revenue Growth
  • EARN 43.30
  • AMRN N/A
  • 52 Week Low
  • EARN $4.33
  • AMRN $7.08
  • 52 Week High
  • EARN $6.99
  • AMRN $20.90
  • Technical
  • Relative Strength Index (RSI)
  • EARN 51.68
  • AMRN 45.88
  • Support Level
  • EARN $5.10
  • AMRN $19.39
  • Resistance Level
  • EARN $5.20
  • AMRN $20.90
  • Average True Range (ATR)
  • EARN 0.08
  • AMRN 0.98
  • MACD
  • EARN 0.04
  • AMRN -0.26
  • Stochastic Oscillator
  • EARN 89.90
  • AMRN 0.00

About EARN Ellington Residential Mortgage REIT of Beneficial Interest

Ellington Credit Co is focused on corporate collateralized loan obligations (CLOs). It focuses on acquiring, investing in, and managing secondary CLO mezzanine debt and equity tranches. The company relies on risk management, including disciplined liquidity management and selective use of credit hedges, to preserve book value during times. The company primary investment objectives are to generate attractive current yields and risk-adjusted total returns for shareholders. It invest in multiple parts of the CLO capital structure, principally mezzanine debt and equity tranches. Rather than focusing only on short-term current yield, it select investments that it believe will provide a strong total return to drive a sustainable earnings stream over a long-term horizon.

About AMRN Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.

Share on Social Networks: